Original Research Obstetrics| Volume 224, ISSUE 1, P95.e1-95.e12, January 2021

Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study


      Aspirin is offered to pregnant women to prevent preeclampsia, a severe obstetrical complication. Large studies of nonpregnant populations have consistently shown that aspirin prophylaxis increases the risk of hemorrhagic complications. However, there have not been any population-based studies investigating this in a pregnant population.


      This study aimed to investigate whether aspirin use during pregnancy is associated with an increased risk of bleeding complications.

      Study Design

      We performed a register-based cohort study using the Swedish Pregnancy Register wherein we examined 313,624 women giving birth between January 2013 and July 2017. Logistic regression was used to assess the risk of antepartum, intrapartum, and postpartum hemorrhage. A propensity score and inverse probability treatment weighting was used to generate an odds ratio that corrects for differences in baseline characteristics.


      Aspirin use was registered in 4088 (1.3%) women during pregnancy. Compared with women who did not take aspirin, aspirin use was not associated with bleeding complications during the antepartum period (adjusted odds ratio, 1.22; 95% confidence interval, 0.97–1.54). However, aspirin users had a higher incidence of intrapartum bleeding (2.9% aspirin users vs 1.5% nonusers; adjusted odds ratio, 1.63; 95% confidence interval, 1.30–2.05), postpartum hemorrhage (10.2% vs 7.8%; adjusted odds ratio, 1.23; 95% confidence interval, 1.08–1.39), and postpartum hematoma (0.4% vs 0.1%; adjusted odds ratio, 2.21; 95% confidence interval, 1.13–4.34). The risk of a neonatal intracranial hemorrhage was also increased (0.07% vs 0.01%; adjusted odds ratio, 9.66; 95% confidence interval, 1.88–49.48). After stratifying by mode of birth, a higher incidence of bleeding among aspirin users was present for those who had a vaginal birth but not those who had a cesarean delivery.


      Using aspirin during pregnancy is associated with increased postpartum bleeding and postpartum hematoma. It may also be associated with neonatal intracranial hemorrhage. When offering aspirin during pregnancy, these risks need to be weighed against the potential benefits.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Ghulmiyyah L.
        • Sibai B.
        Maternal mortality from preeclampsia/eclampsia.
        Semin Perinatol. 2012; 36: 56-59
        • Stuntz M.
        • Bernstein B.
        Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012-2015.
        Prev Med Rep. 2016; 5: 183-186
        • Goodlin R.C.
        • Haesslein H.O.
        • Fleming J.
        Aspirin for the treatment of recurrent toxaemia.
        Lancet. 1978; 2: 51
        • Rolnik D.L.
        • Wright D.
        • Poon L.C.
        • et al.
        Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia.
        N Engl J Med. 2017; 377: 613-622
        • Yu C.K.
        • Papageorghiou A.T.
        • Parra M.
        • Palma Dias R.
        • Nicolaides K.H.
        Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation.
        Ultrasound Obstet Gynecol. 2003; 22: 233-239
        • Bujold E.
        • Roberge S.
        • Lacasse Y.
        • et al.
        Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
        Obstet Gynecol. 2010; 116: 402-414
        • Roberge S.
        • Nicolaides K.
        • Demers S.
        • Hyett J.
        • Chaillet N.
        • Bujold E.
        The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
        Am J Obstet Gynecol. 2017; 216: 110-120.e6
        • CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women
        CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group.
        Lancet. 1994; 343: 619-629
        • Brown M.A.
        • Magee L.A.
        • Kenny L.C.
        • et al.
        Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice.
        Hypertension. 2018; 72: 24-43
        • LeFevre M.L.
        • U.S. Preventive Services Task Force
        Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
        Ann Intern Med. 2014; 161: 819-826
        • Visintin C.
        • Mugglestone M.A.
        • Almerie M.Q.
        • et al.
        Management of hypertensive disorders during pregnancy: summary of NICE guidance.
        BMJ. 2010; 341: c2207
        • Poon L.C.
        • Shennan A.
        • Hyett J.A.
        • et al.
        The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.
        Int J Gynaecol Obstet. 2019; 145: 1-33
        • Lowe S.A.
        • Bowyer L.
        • Lust K.
        • et al.
        SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.
        Aust N Z J Obstet Gynaecol. 2015; 55: e1-e29
        • Tranquilli A.L.
        • Dekker G.
        • Magee L.
        • et al.
        The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP.
        Pregnancy Hypertens. 2014; 4: 97-104
        • Mone F.
        • O’Mahony J.F.
        • Tyrrell E.
        • et al.
        Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women.
        Hypertension. 2018; 72: 1391-1396
        • Mone F.
        • Mulcahy C.
        • McParland P.
        • et al.
        Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial.
        BMJ Open. 2018; 8e022056
        • Mone F.
        • Mulcahy C.
        • McParland P.
        • McAuliffe F.M.
        Should we recommend universal aspirin for all pregnant women?.
        Am J Obstet Gynecol. 2017; 216: 141.e1-141.e5
        • Mallampati D.
        • Grobman W.
        • Rouse D.J.
        • Werner E.F.
        Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis.
        Obstet Gynecol. 2019; 134: 537-544
        • Ikeda Y.
        • Shimada K.
        • Teramoto T.
        • et al.
        Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
        JAMA. 2014; 312: 2510-2520
        • Gaziano J.M.
        • Brotons C.
        • Coppolecchia R.
        • et al.
        Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
        Lancet. 2018; 392: 1036-1046
        • Bowman L.
        • Mafham M.
        • et al.
        • ASCEND Study Collaborative Group
        Effects of aspirin for primary prevention in persons with diabetes mellitus.
        N Engl J Med. 2018; 379: 1529-1539
        • McNeil J.J.
        • Wolfe R.
        • Woods R.L.
        • et al.
        Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.
        N Engl J Med. 2018; 379: 1509-1518
        • Zheng S.L.
        • Roddick A.J.
        Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis.
        JAMA. 2019; 321: 277-287
        • Mahmoud A.N.
        • Gad M.M.
        • Elgendy A.Y.
        • Elgendy I.Y.
        • Bavry A.A.
        Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials.
        Eur Heart J. 2019; 40: 607-617
        • Stephansson O.
        • Petersson K.
        • Björk C.
        • Conner P.
        • Wikström A.K.
        The Swedish Pregnancy Register—for quality of care improvement and research.
        Acta Obstet Gynecol Scand. 2018; 97: 466-476
        • Saunders J.B.
        • Aasland O.G.
        • Babor T.F.
        • de la Fuente J.R.
        • Grant M.
        Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II.
        Addiction. 1993; 88: 791-804
        • Williamson E.J.
        • Forbes A.
        Introduction to propensity scores.
        Respirology. 2014; 19: 625-635
        • Austin P.C.
        An introduction to propensity score methods for reducing the effects of confounding in observational studies.
        Multivariate Behav Res. 2011; 46: 399-424
        • Duley L.
        • Meher S.
        • Hunter K.E.
        • Seidler A.L.
        • Askie L.M.
        Antiplatelet agents for preventing pre-eclampsia and its complications.
        Cochrane Database Syst Rev. 2019; 2019: CD004659
        • Askie L.M.
        • Duley L.
        • Henderson-Smart D.J.
        • Stewart L.A.
        • PARIS Collaborative Group
        Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
        Lancet. 2007; 369: 1791-1798
        • Li L.
        • Geraghty O.C.
        • Mehta Z.
        • Rothwell P.M.
        • Oxford Vascular Study
        Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
        Lancet. 2017; 390: 490-499
        • De Berardis G.
        • Lucisano G.
        • D’Ettorre A.
        • et al.
        Association of aspirin use with major bleeding in patients with and without diabetes.
        JAMA. 2012; 307: 2286-2294
        • Rumack C.M.
        • Guggenheim M.A.
        • Rumack B.H.
        • Peterson R.G.
        • Johnson M.L.
        • Braithwaite W.R.
        Neonatal intracranial hemorrhage and maternal use of aspirin.
        Obstet Gynecol. 1981; 58: 52S-56S
        • Hertz-Picciotto I.
        • Hopenhayn-Rich C.
        • Golub M.
        • Hooper K.
        The risks and benefits of taking aspirin during pregnancy.
        Epidemiol Rev. 1990; 12: 108-148
        • Duley L.
        • Henderson-Smart D.J.
        • Meher S.
        • King J.F.
        Antiplatelet agents for preventing pre-eclampsia and its complications.
        Cochrane Database Syst Rev. 2007; : CD004659
        • Redman C.W.
        • Sargent I.L.
        Latest advances in understanding preeclampsia.
        Science. 2005; 308: 1592-1594
        • Dekker G.A.
        • Sibai B.M.
        Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials.
        Am J Obstet Gynecol. 1993; 168: 214-227
        • Stephansson O.
        • Granath F.
        • Svensson T.
        • Haglund B.
        • Ekbom A.
        • Kieler H.
        Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register.
        Clin Epidemiol. 2011; 3: 43-50
        • Abalos E.
        • Cuesta C.
        • Grosso A.L.
        • Chou D.
        • Say L.
        Global and regional estimates of preeclampsia and eclampsia: a systematic review.
        Eur J Obstet Gynecol Reprod Biol. 2013; 170: 1-7